Sclerostin is a glycoprotein encoded by the sost gene and secreted by osteogenic cells that inhibits bone formation. It can inhibit the signaling pathway by competitively inhibiting the co-receptor-LRP-5 in the Wnt signaling pathway, thereby affecting bone formation.